Glenmark Pharma trades flat despite getting USFDA nod for Theophylline ER tablets Glenmark Pharma trades flat despite getting USFDA nod for Theophylline ER tablets Shruti Dahiwal / Friday, June 4, 2021 / Article rating: 5.0 Glenmark Pharmaceuticals Ltd, a leading pharmaceutical company, announced today that it has received USFDA approval for Theophylline extended-release (ER) tablets of strengths 300 mg & 450 mg.
Ramco Systems surges on announcing digital transformation project of Bristow Group Ramco Systems surges on announcing digital transformation project of Bristow Group Shruti Dahiwal / Wednesday, June 2, 2021 / Article rating: 4.3 Ramco Systems, a next-gen enterprise software company, announced today that it has been selected by Bristow Group Inc., a leading global provider of vertical flight solutions to digitally transform the maintenance & engineering operations of the latter.
Lupin rises on receiving USFDA nod for Pegfilgrastim Biosimilar application Lupin rises on receiving USFDA nod for Pegfilgrastim Biosimilar application Shruti Dahiwal / Wednesday, June 2, 2021 / Article rating: 4.6 Lupin Ltd, a global pharmaceutical company, announced today that it has received the approval from United States Food & Drug Administration (USFDA) for its biologics license application (BLA) of its biosimilar to Neulasta (pegfilgrastim).
Edelweiss signs MoU with Central Bank of India to strengthen co-lending partnership Edelweiss signs MoU with Central Bank of India to strengthen co-lending partnership Shruti Dahiwal / Tuesday, June 1, 2021 / Article rating: 3.7 Edelweiss Retail Finance Limited (ERFL), a subsidiary of Edelweiss Group, announced today that it has signed a new memorandum of understanding (MoU) with Central Bank of India (CBoI).
Marine Electricals order book stands at Rs 441.3 crore with significant wins in 2 months Marine Electricals order book stands at Rs 441.3 crore with significant wins in 2 months Shruti Dahiwal / Monday, May 31, 2021 / Article rating: 3.8 Marine Electricals (India) Limited, a company engaged in the provision of integrated electrical solutions, announced this morning that it has bagged orders worth Rs 40 crore in the last two months, i.e., in the months of April and May.
Zydus signs agreement with TLC to commercialise black fungus treatment drug Zydus signs agreement with TLC to commercialise black fungus treatment drug Shruti Dahiwal / Wednesday, May 26, 2021 / Article rating: 4.0 Zydus Cadila, a leading pharmaceutical company, announced today that it has entered into a licence supply & commercialisation agreement with Taiwan Liposome Company (TLC), a Taiwan-based pharmaceutical company.
Zydus Cadila gains on launching Ujvira, a novel breast cancer treatment drug. Zydus Cadila gains on launching Ujvira, a novel breast cancer treatment drug. Shruti Dahiwal / Monday, May 24, 2021 / Article rating: 4.0 Zydus Cadila, a leading pharmaceutical company, announced this morning the launch of Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) under the brand name of ‘Ujvira’.
Cipla to distribute Roches anti-body cocktail, a Covid-19 treatment drug in India Cipla to distribute Roches anti-body cocktail, a Covid-19 treatment drug in India Shruti Dahiwal / Monday, May 24, 2021 / Article rating: 3.3 Cipla Limited, a leading pharmaceutical company announced today that it is going to distribute an anti-body of Casirivimab and Imdevimab drugs across India. This anti-body cocktail is a product of Roche Pharma India.
Dishman Carbogen gains on discovering treatment for vitamin D deficiency Dishman Carbogen gains on discovering treatment for vitamin D deficiency Shruti Dahiwal / Friday, May 21, 2021 / Article rating: 4.3 Dishman Carbogen Amcis Ltd (DCAL), a multinational pharmaceutical company, announced this afternoon that it has achieved successful results in its research for treatment for vitamin D deficiency.
Morepen to receive investments worth Rs 243 crore from Corinth Investment Holdings Morepen to receive investments worth Rs 243 crore from Corinth Investment Holdings Shruti Dahiwal / Friday, May 21, 2021 / Article rating: 3.6 Morepen Laboratories Limited, a domestic pharmaceutical company, announced this morning that in the Extra-Ordinary General Meeting (EGM), its shareholders have given a go-ahead for issuing and allotting 585 lakh equity shares worth Rs 243.36 crore to Corinth Investment Holdings AG (headquartered in Switzerland).